Regentis Increases GelrinC Production Yield 400% with Solvent-Free Process
Regentis Biomaterials has patented a solvent-free manufacturing process for GelrinC that increases production yield by 400% and removes flammable organic solvents. Patents have been granted in India, China and Israel, with U.S. approval pending, as the company prepares for a commercial launch in Europe later this year.
1. Manufacturing Process Improvement
Regentis has developed a proprietary solvent-free process for GelrinC production that eliminates flammable organic solvents and increases batch yield by 400%, significantly reducing material waste and shortening production cycles.
2. Patent Filings and Grants
Patents for the new solvent-free manufacturing method have been granted in India, China and Israel, with a U.S. patent application currently pending, securing intellectual property rights across key markets.
3. Preparing for European Commercial Launch
The company is integrating the high-yield process into its supply chain ahead of GelrinC’s planned launch in Europe later this year, aiming to improve production economics and enhance gross margins upon market entry.